A detailed history of Nebula Research & Development LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 106,434 shares of PACB stock, worth $145,814. This represents 0.09% of its overall portfolio holdings.

Number of Shares
106,434
Holding current value
$145,814
% of portfolio
0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $374,647 - $1.02 Million
106,434 New
106,434 $399 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $161,275 - $272,972
19,596 New
19,596 $164 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $308M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.